MarketsNotableEmergingDeveloping
5.4
Oncoclínicas tender offer valuation estimated at R$ 11.7 billion
Valor Econômico·BR·2 days ago
MarketsConfirmedMediumDeveloping
5.9
Centaurus Capital mandated to launch tender offer for Oncoclínicas by October 24
Centaurus Capital must initiate a tender offer for Oncoclínicas (ONCO3) shares by October 24, 2026, following a regulatory trigger from the CVM. The offer price will be indexed to the Selic rate, reflecting a mandatory acquisition process under Brazilian securities law.
Score Breakdown
Mosaic Score5.9
Confidence0.9
Significance0.5
Source credibility0.5
Related signals
8 foundMarketsNotableConfirmedDeveloping
6.9
Ibovespa extends winning streak to eight sessions despite Fed rate hike speculation
Valor Econômico·BR · US·1 day ago
MarketsNotableConfirmed
6.9
Brazil records $1.689 billion net inflow into equity markets in July
InfoMoney·BR·2 days ago
MarketsNotableConfirmedDeveloping
6.4
Internal friction rises between CVM board and technical staff regarding regulatory enforcement
Valor Econômico·BR·1 day ago
MarketsNotableConfirmedDeveloping
5.9
Foreign capital inflows into B3 equities continue for fourth consecutive session
Valor Econômico·BR·1 day ago
MarketsNotableConfirmed
5.9
Braskem shares surge 14% following Petrobras credit line expansion
InfoMoney·BR·2 days ago
MarketsNotableConfirmedDeveloping
5.9
CVM mandates Oncoclínicas tender offer, sparking shareholder eligibility disputes
Valor Econômico·BR·1 day ago
MarketsNotableSingle-sourceDeveloping
5.4
CVM mandates Oncoclínicas tender offer with Selic-adjusted valuation
Valor Econômico·BR·3 days ago